Pharmaceutical

Filter

Current filters:

None

Popular Filters

64 to 88 of 7086 results

Astellas links with Harvard to discover new ophthalmic agents

14-10-2014

Japanese drug major Astellas Pharma has entered into a research collaboration with an investigator at…

Astellas PharmaLicensingOphthalmicsPharmaceuticalResearch

EXPERT VIEW: Ethnobridging and the Asian market

EXPERT VIEW: Ethnobridging and the Asian market

14-10-2014

Financial and competitive pressures mean that multinational pharmaceutical companies are constantly looking…

Asia-PacificChinaParexel InternationalPharmaceuticalResearch

Call for India’s Prime Minister to restore drug price caps

14-10-2014

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program,…

IndiaPatentsPharmaceuticalPoliticsPricing

Novartis is fined by Indian pricing authority over Voveran

Novartis is fined by Indian pricing authority over Voveran

14-10-2014

Swiss pharma major Novartis has received a penalty charge of 3 billion rupees from the Indian National…

AnalgesiadiclofenacIndiaLegalNovartisPharmaceutical

Saudi Arabian pharma needs to reconsider its business proposition to compete with global giants

Saudi Arabian pharma needs to reconsider its business proposition to compete with global giants

14-10-2014

The Saudi Arabian pharma market is a changing landscape in the face of the physical penetration of international…

GSKMarkets & MarketingPfizerPharmaceuticalSaudi Arabia

WHO cancer agency launches new European Code Against Cancer

WHO cancer agency launches new European Code Against Cancer

14-10-2014

The specialized cancer agency of the World Health Organization, the International Agency for Research…

CancerEuropeHealthcareOncologyPharmaceutical

Boehringer Ingelheim gets two drugs approved by Scotland’s health watchdog

14-10-2014

The UK subsidiary of German family-owned pharma major Boehringer Ingelheim announced today that, following…

Boehringer IngelheimCardio-vascularDiabetesJardiancePharmaceuticalPradaxaPricingUK

Bengt Julander appointed chairman of the board at Pharmalink

Bengt Julander appointed chairman of the board at Pharmalink

14-10-2014

Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the…

BoardroomPharmaceuticalPharmaLinkPharmaLinkSweden

“Industry Innovation Competitiveness Agenda” applauded by Medicines Australia

14-10-2014

The Australian government’s Industry Innovation and Competitiveness Agenda and the announcement of…

AustraliaPharmaceuticalPoliticsProductionResearch

Pfizer’s palbociclib gains FDA Priority Review

13-10-2014

Pfizer says that the New Drug Application for its investigational breast cancer treatment palbociclib…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

New Ph III data to support filing for AbbVie’s Humira in HS

13-10-2014

US pharma company AbbVie has reported new data with its mega blockbuster arthritis drug Humira (adalimumab)…

AbbVieAnti-Arthritics/RheumaticsDermatologicalsHumiraPharmaceuticalResearch

New study finds fewer drugs covered by USA’s Medicare

13-10-2014

An analysis of US government data on 2015 Medicare drug plans by HealthPocket has found that the average…

FinancialHealthcarePharmaceuticalUSA

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

Shire awards 10,000 euros to ADHD patient groups

Shire awards 10,000 euros to ADHD patient groups

13-10-2014

Ireland-based pharma company Shire announced the winners of the 2014 Excellence in ADHD Patient Group…

Adderall XREuropeHealthcareIrelandNeurologicalPharmaceuticalShireVyvanse

FDA approves Eisai’s Akynzeo for CINV

13-10-2014

The US Food and Drug Administration has approved Japanese pharma major Eisai’s Akynzeo (netupitant…

AkynzeoEisaiHelsinnnetupitantOncologypalonosetronPharmaceuticalRegulationUSA

Novartis suspends commissioning of new Russian plant

13-10-2014

Swiss pharma major Novartis has decided to suspend the commissioning of its new Russian plant, which…

FinancialNovartisPharmaceuticalProductionRussia

Russia to start vaccines supplies to Central and South America

13-10-2014

Russia plans to start active supplies of vaccines to the Central and South America region during the…

Markets & MarketingPharmaceuticalProductionRussiaSouth AmericaVaccines

Hikma to distribute Eisai’s Fycompa in Middle East

13-10-2014

Hikma Pharmaceuticals has entered into a partnership with Japanese pharma major Eisai for the distribution…

EisaiFycompaHikma PharmaceuticalsJordanLicensingMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldSaudi Arabia

Positive Ph III results for Ipsen’s Decapeptyl in prostate cancer patients

12-10-2014

French drugmaker Ipsen has released positive results from the Phase III study of Decapeptyl (triptorelin…

DecapeptylIpsenOncologyPharmaceuticalResearch

Highlights from EMA Pharmacovigilance October meeting

10-10-2014

At its October meeting, the European Medicines Agency’ Pharmacovigilance Risk Assessment Committee…

Ariad PharmaceuticalsEuropeIclusigMen's HealthNeurologicalOncologyPharmaceuticalRegulationTestosteronevalproate

BTG settles CroFab patent litigation with Bioclon and RDT

10-10-2014

UK specialist health care company BTG says it has settled its US patent infringement complaint against…

BTGCrofabInstituto BioclonLegalPatentsPharmaceuticalRare Disease TherapeuticsRare diseasesUSA

New Zealand approval of Novartis multiproduct proposal

10-10-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

NeurologicalNew ZealandOncologyPharmaceuticalRegulationRespiratory and Pulmonary

64 to 88 of 7086 results

Back to top